189 related articles for article (PubMed ID: 32112128)
1. The importance of local control management in high-risk neuroblastoma in South Africa.
van Heerden J; Kruger M; Esterhuizen T; Hendricks M; Geel J; Büchner A; Naidu G; du Plessis J; Vanemmenes B; Uys R; Hadley GP;
Pediatr Surg Int; 2020 Apr; 36(4):457-469. PubMed ID: 32112128
[TBL] [Abstract][Full Text] [Related]
2. Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis.
Simon T; Häberle B; Hero B; von Schweinitz D; Berthold F
J Clin Oncol; 2013 Feb; 31(6):752-8. PubMed ID: 23284039
[TBL] [Abstract][Full Text] [Related]
3. Overall survival for neuroblastoma in South Africa between 2000 and 2014.
Van Heerden J; Hendricks M; Geel J; Sartorius B; Hadley GP; Du Plessis J; Büchner A; Naidu G; Van Emmenes B; Van Zyl A; Kruger M
Pediatr Blood Cancer; 2019 Nov; 66(11):e27944. PubMed ID: 31368239
[TBL] [Abstract][Full Text] [Related]
4. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
[TBL] [Abstract][Full Text] [Related]
5. Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study.
Holmes K; Pötschger U; Pearson ADJ; Sarnacki S; Cecchetto G; Gomez-Chacon J; Squire R; Freud E; Bysiek A; Matthyssens LE; Metzelder M; Monclair T; Stenman J; Rygl M; Rasmussen L; Joseph JM; Irtan S; Avanzini S; Godzinski J; Björnland K; Elliott M; Luksch R; Castel V; Ash S; Balwierz W; Laureys G; Ruud E; Papadakis V; Malis J; Owens C; Schroeder H; Beck-Popovic M; Trahair T; Forjaz de Lacerda A; Ambros PF; Gaze MN; McHugh K; Valteau-Couanet D; Ladenstein RL;
J Clin Oncol; 2020 Sep; 38(25):2902-2915. PubMed ID: 32639845
[TBL] [Abstract][Full Text] [Related]
6. The evaluation of induction chemotherapy regimens for high-risk neuroblastoma in South African children
Van Heerden J; Geel J; Hendricks M; Wouters K; Büchner A; Naidu G; Hadley GP; Du Plessis J; Van Emmenes B; Van Zyl A; Vermeulen J; Kruger M
Pediatr Hematol Oncol; 2020 May; 37(4):300-313. PubMed ID: 32075464
[TBL] [Abstract][Full Text] [Related]
7. Survival outcome of intermediate risk neuroblastoma at Children Cancer Hospital Egypt.
Elzomor H; Ahmed G; Elmenawi S; Elkinaai N; Refaat A; Soliman S; Abdelwahab MA; Zaghloul MS; Fawzy M
J Egypt Natl Canc Inst; 2018 Mar; 30(1):21-26. PubMed ID: 29428371
[TBL] [Abstract][Full Text] [Related]
8. Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants.
Marcus KJ; Shamberger R; Litman H; von Allmen D; Grupp SA; Nancarrow CM; Goldwein J; Grier HE; Diller L
J Pediatr Hematol Oncol; 2003 Dec; 25(12):934-40. PubMed ID: 14663275
[TBL] [Abstract][Full Text] [Related]
9. Neuroblastoma in adolescents: the Italian experience.
Conte M; Parodi S; De Bernardi B; Milanaccio C; Mazzocco K; Angelini P; Viscardi E; Di Cataldo A; Luksch R; Haupt R
Cancer; 2006 Mar; 106(6):1409-17. PubMed ID: 16475209
[TBL] [Abstract][Full Text] [Related]
10. Neuroblastoma: outcome over a 14 year period from a tertiary care referral centre in India.
Agarwala S; Mandelia A; Bakhshi S; Srinivas M; Bajpai M; Gupta AK; Gupta DK; Bhatnagar V
J Pediatr Surg; 2014 Aug; 49(8):1280-5. PubMed ID: 25092090
[TBL] [Abstract][Full Text] [Related]
11. A single center clinical analysis of children with high-risk neuroblastoma.
Tian X; Cao Y; Wang J; Yan J; Tian Y; Li Z; Wang H; Duan X; Jin Y; Zhao Q
Oncotarget; 2017 May; 8(18):30357-30368. PubMed ID: 28423674
[TBL] [Abstract][Full Text] [Related]
12. Real World Experience of Treating Neuroblastoma: Experience from a Tertiary Cancer Centre in India.
Radhakrishnan V; Raja A; Dhanushkodi M; Ganesan TS; Selvaluxmy G; Sagar TG
Indian J Pediatr; 2019 May; 86(5):417-426. PubMed ID: 30778950
[TBL] [Abstract][Full Text] [Related]
13. The pre-surgical factors that determine the decision to proceed to resection in children diagnosed with high-risk neuroblastoma in a resource limited setting.
van Heerden J; Kruger M; Esterhuizen TM; van Zyl A; Hendricks M; Cox S; Mangray H; Poole J; Naidu G; Büchner A; de Villiers M; du Plessis J; van Emmenes B; Matthews E; Manickchund Y; Harrison DS
Pediatr Hematol Oncol; 2023 Apr; 40(3):242-257. PubMed ID: 36271813
[TBL] [Abstract][Full Text] [Related]
14. Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes.
Avanzini S; Pio L; Erminio G; Granata C; Holmes K; Gambart M; Buffa P; Castel V; Valteau Couanet D; Garaventa A; Pistorio A; Cecchetto G; Martucciello G; Mattioli G; Sarnacki S
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28440012
[TBL] [Abstract][Full Text] [Related]
15. Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months.
Fischer J; Pohl A; Volland R; Hero B; Dübbers M; Cernaianu G; Berthold F; von Schweinitz D; Simon T
BMC Cancer; 2017 Aug; 17(1):520. PubMed ID: 28778185
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of outcome and prognostic factors in thoracic primitive neuroectodermal tumor: a study of 84 cases.
Biswas B; Agarwala S; Shukla NK; Deo S; Sharma D; Thulkar S; Vishnubhatla S; Bakhshi S
Ann Thorac Surg; 2013 Dec; 96(6):2006-14. PubMed ID: 24035307
[TBL] [Abstract][Full Text] [Related]
17. Outcomes and complications of surgery in patients with intermediate-risk neuroblastoma: experience from an Indian tertiary Cancer Centre.
Qureshi SS; Bhagat M; Harris C; Chinnaswamy G; Vora T; Kembhavi S; Prasad M; Ramadwar M; Shetty O; Laskar S; Khanna N; Amin N; Talole S
Pediatr Surg Int; 2018 Apr; 34(4):435-442. PubMed ID: 29487992
[TBL] [Abstract][Full Text] [Related]
18. Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study.
Alvarado CS; London WB; Look AT; Brodeur GM; Altmiller DH; Thorner PS; Joshi VV; Rowe ST; Nash MB; Smith EI; Castleberry RP; Cohn SL
J Pediatr Hematol Oncol; 2000; 22(3):197-205. PubMed ID: 10864050
[TBL] [Abstract][Full Text] [Related]
19. Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children > 1 year with residual local disease.
Simon T; Hero B; Bongartz R; Schmidt M; Müller RP; Berthold F
Strahlenther Onkol; 2006 Jul; 182(7):389-94. PubMed ID: 16826357
[TBL] [Abstract][Full Text] [Related]
20. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
